Literature DB >> 9601495

The first strand transfer during HIV-1 reverse transcription can occur either intramolecularly or intermolecularly.

J L van Wamel1, B Berkhout.   

Abstract

Reverse transcription is a complicated process that involves at least two cDNA transfer reactions to produce a full-length copy DNA of the retroviral RNA genome. Because one retrovirus particle contains two identical genomic RNA molecules, the transfers can occur in an intramolecular or intermolecular manner. The mechanism of the first transfer step (minus-strand strong-stop cDNA transfer) has been studied previously in detail in transduction experiments with spleen necrosis virus vectors containing genetic markers. Different results have been reported with respect to the type of strand transfer mechanism. In this study, we analyzed the first strand transfer for human immunodeficiency virus type 1 (HIV-1). Two genetically marked genomes were copackaged into virions and reverse transcription was initiated within these particles upon permeabilization by NP-40 and addition of dNTPs. To test whether intrastrand or interstrand transfer had occurred, the cDNA products of this endogenous reverse transcription reaction were extracted from the virions and analyzed for the presence of restriction enzyme recognition sites provided by the genetic markers. The results of this analysis demonstrated that the first DNA transfer reaction occurs in a random manner, with approximately the same contribution of intrastrand and interstrand transfers. The ability to perform intermolecular strand transfer was lost upon extraction of the dimeric RNA template from the virion particle.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9601495     DOI: 10.1006/viro.1998.9096

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication.

Authors:  J K Pfeiffer; A Telesnitsky
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  A short sequence motif in the 5' leader of the HIV-1 genome modulates extended RNA dimer formation and virus replication.

Authors:  Nikki van Bel; Atze T Das; Marion Cornelissen; Truus E M Abbink; Ben Berkhout
Journal:  J Biol Chem       Date:  2014-11-03       Impact factor: 5.157

Review 3.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 4.  HIV-1 reverse transcription.

Authors:  Wei-Shau Hu; Stephen H Hughes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

5.  Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivo.

Authors:  J G Mikkelsen; A H Lund; M Duch; F S Pedersen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  High rate of recombination throughout the human immunodeficiency virus type 1 genome.

Authors:  A E Jetzt; H Yu; G J Klarmann; Y Ron; B D Preston; J P Dougherty
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 7.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

8.  High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy.

Authors:  Jianling Zhuang; Sayandip Mukherjee; Yacov Ron; Joseph P Dougherty
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 9.  Reverse Transcription of Retroviruses and LTR Retrotransposons.

Authors:  Stephen H Hughes
Journal:  Microbiol Spectr       Date:  2015-04

10.  Structural features in the HIV-1 repeat region facilitate strand transfer during reverse transcription.

Authors:  B Berkhout; N L Vastenhouw; B I Klasens; H Huthoff
Journal:  RNA       Date:  2001-08       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.